Results 111 to 120 of about 216,038 (323)

Pathogenesis of Age‐Related Hearing Loss and Therapeutic Strategies

open access: yesSensory Neuroscience, EarlyView.
ABSTRACT Age‐related hearing loss (ARHL) is a degenerative disorder of the auditory system, characterized by bilateral symmetrical sensorineural hearing loss that occurs with aging. As a highly prevalent age‐related condition worldwide, ARHL significantly impairs both the quality of life and mental health of the elderly.
Yu Xiao   +6 more
wiley   +1 more source

Association between cholesterol gallstones and testosterone replacement therapy in a patient with primary hypogonadism

open access: yesRevista de Gastroenterología de México (English Edition), 2018
A 16-year-old boy had a past medical history of primary hypogonadism, due to bilateral anorchia. He presented with gallstones located in the gallbladder and a mild dilatation of the intrahepatic biliary tree.
S. Squarza   +3 more
doaj   +1 more source

Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report. [PDF]

open access: yes, 2008
Prokineticin 2 (Prok2) or prokineticin-receptor2 (Prok-R2) gene mutations are associated with Kallmann syndrome (KS). We describe a new homozygous mutation of Prok-R2 gene in a man displaying KS with an apparent reversal of hypogonadism.
Asci R   +8 more
core   +1 more source

Assessing the utility of a natural language processing model in answering common urological questions

open access: yesUroPrecision, EarlyView.
ABSTRACT Background ChatGPT, an interactive natural language processing model, is becoming increasingly used for medical information gathering. The objective of this study is to investigate the appropriateness of ChatGPT's responses to common urological questions compared to the Canadian Urological Association (CUA) guideline recommendations. Methods A
Wyatt MacNevin   +6 more
wiley   +1 more source

Development of a men's Preference for Testosterone Replacement Therapy (P-TRT) instrument

open access: yesPatient Preference and Adherence, 2012
Sheryl L Szeinbach,1 Enrique Seoane-Vazquez,2 Kent H Summers31Ohio State University, College of Pharmacy, Columbus, OH, USA; 2International Center for Pharmaceutical Economics and Policy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA,
Szeinbach SL   +2 more
doaj  

Phosphodiesterase Type 5 Inhibitors, Sport and Doping [PDF]

open access: yes, 2017
Phosphodiesterase type 5 inhibitors (PDE5i) (e.g., sildenafil, tadalafil, vardenafil, and avanafil) are drugs commonly used to treat erectile dysfunction, pulmonary arterial hypertension, and benign prostatic hyperplasia.
Borrione, Paolo   +8 more
core   +1 more source

Effects of two‐year testosterone replacement therapy on cognition, emotions and quality of life in young and middle‐aged hypogonadal men

open access: yesAndrologia, 2017
The aim of the study was to examine the effects of two‐year testosterone replacement therapy on cognitive functioning, emotional state and quality of life in young and middle‐aged men with hypogonadotropic hypogonadism.
L. Lašaitė   +3 more
semanticscholar   +1 more source

Review on enhancing clinical decision support system using machine learning

open access: yesCAAI Transactions on Intelligence Technology, EarlyView.
Abstract Clinical decision‐making is a complex patient‐centred process. For an informed clinical decision, the input data is very thorough ranging from detailed family history, environmental history, social history, health‐risk assessments, and prior relevant medical cases.
Anum Masood   +4 more
wiley   +1 more source

Evaluation of the effect of testosterone replacement therapy with a transdermal testosterone on glycemic control in men with type 2 diabetes mellitus

open access: yesСахарный диабет
BACKGROUND: It is important to evaluate the effect of androgen replacement therapy on glycemic control.AIMS: Assessment of the effect of transdermal testosterone therapy on glycemic control in men with hypogonadism and T2DM.MATERIALS AND METHODS: The ...
R. V. Rozhivanov   +7 more
doaj   +1 more source

LATE ONSET HYPOGONADISM: TO TREAT, NOT TO TREAT AND WHO MUST TREAT?

open access: yesВестник урологии, 2016
The article presents a review of the literature, which indicate the current understanding of the clinical significance of late onset hypogonadism and types of its correction.
Z. R. Gusova   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy